跳至主要内容
临床试验/NL-OMON45310
NL-OMON45310撤回不适用

Deferoxamine in Aneurysmal Subarachnoid Hemorrhage trial - DASH

Radboud Universitair Medisch Centrum0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
撤回
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • * Male or Female,
  • * 18-85 years old inclusive,
  • * subarachnoid hemorrhage diagnosed by CT on admission,
  • * Randomizable within 72 hours of subarachnoid hemorrhage,
  • * Saccular intracranial aneurysm proven by cerebral angiography or CTA,
  • * Surgical or endovascular obliteration is performed,
  • * Able to obtain written informed consent from patient or surrogate.
  • * Patients in good clinical grade (WFNS 1-3)

排除标准

  • * Pregnancy, as confirmed by routine urine test on admission,
  • * Abnormal renal function at time of randomization (GFR <60 mL/min)
  • * Elevated liver function test at time of randomization (AST > 45 U/L and ALT > 35 U/L.)
  • * History of liver disease or active liver disease, Active renal disease,
  • * Hypersensitivity to deferoxamine,
  • * Patient taking medication not recommended for concomitant use with deferoxamine as per the product label (e.g. high dose vit. C medication).
  • * Patients not able to complete the study follow-up.

研究者

相似试验